The Latest
Leads Biolabs’ PD-L1/4-1BB Bispecific Antibody IND Application For Combination Therapy In Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise
Leads Biolabs has submitted an IND application for its PD-L1/4-1BB bispecific antibody targeting metastatic colorectal cancer, advancing its gastrointestinal oncology portfolio.